Studie Biotechnologie

A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when Romans, Chinese, and Aztecs used gold for dental applications. Biomaterials, which are also biocompatible, have since been adapted, improvised, and technically enabled to improve body functions and replace damaged tissues. They have evo... mehr

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently being marketed; 90% of them are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications... mehr

Introduction

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology... mehr

Introduction

Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium biotechnology market. I... mehr

Introduction

Biotechnology in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada biotechnology market. Inc... mehr

Introduction

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China biotechnology market. Inclu... mehr

Introduction

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe biotechnology market. Inc... mehr

Introduction

Biotechnology in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France biotechnology market. Inc... mehr

Introduction

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany biotechnology market. I... mehr

Introduction

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy biotechnology market. Inclu... mehr

Introduction

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Inclu... mehr

Introduction

Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain biotechnology market. Inclu... mehr

Introduction

Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands biotechnolo... mehr

Introduction

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom biote... mehr

Introduction

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United States biotech... mehr

Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an execu... mehr

Introduction

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global biotechnology market. Includ... mehr

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies

Summary

GBI Research's report, 'Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges and drivers for the downstream industry. The... mehr

Introduction

Datamonitor's retail databooks are based on key market value data for eight major product sectors, 16 core retail distribution channels and 62 countries. This profile focuses on and provides data on channel size. It also offers information on main markets sold through the channel, and includes growth forecasts upto 2013.

Scope

*An overview of total retail value in this country segmented by ... mehr

Biotechnology Pharmaceutical Market in US 2009-2013 report by Technavio Insights forecasts the Biotechnology Pharmaceutical market to grow at a CAGR of 7.7 percent, with Blood Modifiers accounting for the largest share of the market at 36.3 percent.


The major growth drivers include:
- Increasing demand for biotechnology drugs with enhanced efficiency, safety and popularity
- Revision of regulations and standar... mehr

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Global Life Sciences Tools and Services Market 2009-2013 report by Technavio Insights forecasts the Life Sciences Tools and Services market to grow at a CAGR of 10.1 percent, with Americas (including North America and Latin America) having the largest market share of 59.6 percent.

The major growth drivers include:
- Both increasing demand for clinical services and increasing complexity of clinical trial research, which i... mehr

Report description

Bioinformatics has gained high importance due to its ability to facilitate rapid clinical research, and also due to its various applications such as gene therapy and molecular science. Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increas... mehr

The funding landscape for small and mid-cap biomedical companies has changed enormously over the past two years, driven by recessive public markets and withdrawal of private equity financing. The cost of raising capital has increased, and investors have become very selective about the type of transactions they participate in. Most small biopharma ventures are struggling to raise funds and maintain enough working capital for their clinic... mehr

The pharmaceuticals and biotechnology sectors are currently facing increasing time and cost issues related to clinical trials in drug discovery. The cost of developing a new drug can reach $2 billion; clinical trials, regulatory approval and subsequent launch may take up to a decade.
Biomarkers reduce the attrition rate of late stage clinical trials by assessing drug potential in terms of efficacy and toxicity at the early stages ... mehr

Summary:'Competing For Share Of Global Pharmaceutical Industry Spend In 2010-2011” is a new report published by ICD Research that analyzes how industry suppliers’ media spend, marketing and sales strategies & practices and business planning will be shaped in 2010 to 2011. In an uncertain economic climate this report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, busin... mehr

The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity to detect early, and cost. Cost currently remains a major constraint, as people and healthcare institutes are skeptical of investing in technologies that have not provided very wide and acceptable results. The impact of cost constraints will diminish as the cost/value benefit is... mehr

Monoclonal antibodies form the fastest growing segment of the pharmaceutical industry, with total annual sales expected to top $50 billion in the next four years. 23 full-size monoclonal antibodies and three monoclonal antibody fragments have been launched so far, several having quickly reached ‘blockbuster status’ (annual sales of over $1 billion). Between 1995 and 2007, the number of monoclonal antibody-based drug candidates enter... mehr

Drug developers have long been under pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition. Current weak economic conditions have exacerbated these challenges with sweeping R&D staff and budget reductions. In order to remain competitive, drug makers must now do more with less. Technology transfer, particularly of new biotechnologies that offe... mehr

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma”, which provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where RNA therapies can pr... mehr

Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis”. It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key t... mehr

Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline, which provides an insight into the global biotechnology industry and analyzes the compet... mehr

Nutrigenomics explores how nutrients or bioactive dietary compounds can influence gene expression and an individuals risk to certain diseases. Nutrigenetics is the study of how variations in an individual’s genetic makeup can increase or decrease the need for a specific nutrient or bioactive food component.
Nutrigenomics has the potential to impact various parts of the food chain including the genetic modification of crops and a... mehr

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways�. The report provides insights on the biosimilars market revenues and growth until 2015. Further, the distribution of revenues across key geographies such as the US, the top five countries in Europe and Japan are provided i... mehr

The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Summary

GBI Research, the leading business intelligence provider, has released its latest research “The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers ... mehr

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global monoclonal antibodies market. The report analyzes the markets for monoclonal antibodies in the US, the t... mehr

Report Description

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are... mehr

The study of epigenetics - changes in gene expression that occur without a change in a cell’s DNA code — is becoming increasingly important as scientists explore how internal and external factors trigger cellular dysfunction and influence disease progression. Three main mechanisms - DNA methylation, histone modifications and changes in non-coding RNA - have been elucidated in epigenetics. Each in its own way may provide the ind... mehr

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Introduction

The life sciences industry is unique and complex. Without having the proper background, it can be difficult for IT vendors to enter this conservative market. Those willing to put in the extra effort to truly understand the pharmaceutical and biotechnology industries will realize there is considerable opportunity for technology.

Scope

*Offers an overview of the pharmaceutical and biotechnolog... mehr

Report Description

The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

The global biomarker market is estimated to be $20.5 billion by 20... mehr

Report Description

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into peptid... mehr

Report Description

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composite... mehr

Introduction

The major contemporary bioterrorist event which has opened up programs of research and development (R&D) in pharmaceutical countermeasures and treatments was the anthrax mail attacks which occurred only weeks after the 9/11 atrocities, in October 2001. The mailings killed five people and exposed hundreds more — with thousands of US citizens seeking prophylactic antibiotics. Since then the biodefense ind... mehr

Introduction

The major contemporary bioterrorist event which has opened up programs of research and development (R&D) in pharmaceutical countermeasures and treatments was the anthrax mail attacks which occurred only weeks after the 9/11 atrocities, in October 2001. The mailings killed five people and exposed hundreds more — with thousands of US citizens seeking prophylactic antibiotics. Since then the biodefense ind... mehr

Introduction

The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical testing have forced the drug manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies whi... mehr

Introduction

Rising costs and falling productivity, among other trends are driving pharmaceutical companies to outsource an increasing range of functions to CROs in search of time and cost savings. This produced strong double-digit growth in the sector between 2003 and 2008. However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook... mehr

Scope:

‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.

The report includes the following:

— Industry analysis including market value, market volume, market share and forecast growth till 2012
— Assessment of intensity ... mehr

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry.

In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a v... mehr

Biotechnology ventures involve costly research and development and a 10-20 year delay in generating product revenues. The high risk nature of early stage biotech research is primarily funded through venture capital, with high risks resulting in potentially high rewards. While the biotech venture model has remained relatively unchanged over the past 30 years, the exit strategies employed by companies and venture capitalists have adapted ... mehr

Datamonitor's Global Pharmaceuticals, Biotechnology & Life Sciences industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals, biotechnology & life sciences industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* C... mehr

Datamonitor's Global Pharmaceuticals, Biotechnology & Life Sciences industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals, biotechnology & life sciences industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* C... mehr

The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery

Report Overview

Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large population-based biobanks have been established which monitor the health status of participants over time to assess the natural occurrence and progression of common d... mehr

Industrialization is changing the dynamics of the global seeds industry. The agriculture land is not going to increase over a period of time; in fact, it is decreasing owing to the growing industrialization world over. The agricultural land is increasingly being used for setting up of industries. This is putting pressure on agricultural sector as the increasing population is driving food demand.

The need of the hour is to pro... mehr

Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, recent trends have shown improvements in staffing, expertise and service levels. However, the tech transfer function has recently suffered from ‘funding gaps’ for promising new technol... mehr

Emerging drug delivery technologies aim to improve measures of safety, efficacy, convenience and compliance in both new and existing drug candidates and products. For currently marketed products, reformulations with new delivery technologies will extend the period of patent protection. New formulas will be key to boosting sales volume of large molecule products in chronic diseases where patient compliance surrounding dosing strategies a... mehr

Introduction

Technology markets are changing fast. This brief is essential reading for you to identify the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline the changes in your market, explain which trends will have the biggest impact and highlight who will benefit from the developments in pharmaceutical technology.

Scope<... mehr

Introduction

Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines.

Scope

*Overview licensing trends up until the credit crisis

*Strategic analysis of biotech's funding crisis

*Insight into how the ... mehr

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.... mehr

Introduction

This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests which are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic (IVD) market from 2007-13 also provided

Scope
mehr

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.... mehr

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.... mehr

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.... mehr

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.... mehr

Successful Pharma-Biotech Alliance Strategies
Driving synergies, avoiding failure and managing relationships
The average value of pharma-biotech deals will almost treble by 2015 as pharma companies focus on gaining exclusive access to high potential technologies via large equity investments...
In recent years, alliances between pharma and biotech companies have become increasingly common.The potential synergistic benefit... mehr